Information for "Caplacizumab with regard to Acute Thrombotic Thrombocytopenic Purpura"
Jump to navigation
Jump to search
View the protection log for this page.
Basic information
| Display title | Caplacizumab with regard to Acute Thrombotic Thrombocytopenic Purpura |
| Default sort key | Caplacizumab with regard to Acute Thrombotic Thrombocytopenic Purpura |
| Page length (in bytes) | 6,563 |
| Page ID | 966137 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Monthdream9 (talk | contribs) |
| Date of page creation | 08:00, 3 November 2024 |
| Latest editor | Monthdream9 (talk | contribs) |
| Date of latest edit | 08:00, 3 November 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |